Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience.
OBJECTIVE
To evaluate the prevalence and characteristics of different neurological and psychiatric presentations in patients admitted to hospital with systemic lupus erythematosus (SLE).


METHODS
In this retrospective hospital-based study, we examined the medical records of patients with SLE who were referred to the hospitals affiliated to Shiraz University of Medical Sciences from 1995 to 2005. All patients of SLE who had clinical neurological or psychiatric features were included in this study. The patients demographic data, findings on general examination, neuropsychiatric manifestations, and the results of laboratory investigations and imaging studies were recorded. Clinical manifestations were classified according to the American College of Rheumatology (ACR) case definitions.


RESULTS
Of the 407 study patients, 11.3% had neuropsychiatric complications. The most frequent findings were seizure (63%), headache (60%), and decreased level of consciousness (50%). Cerebrovascular disease (28.3%), seizure disorder (26.5%), and acute confusional state (19.6%) were the most prevalent syndromes.


CONCLUSIONS
The prevalence and nature of different neurological presentations of SLE in Iranian patients has some similarities to that seen in other populations, as well as some differences. Ethnic and environmental factors may contribute to these differences.
Borhani Haghighi
Afshin
A
Transgenic Technology Research Center and Departments of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran. borhanihaghighi@yahoo.com
Haza
Shahab Ghasem
SG
Lupus. 1993 Aug;2(4):281-3
8268979
Neurol India. 2006 Mar;54(1):75-7
16679649
Arthritis Rheum. 1992 Apr;35(4):411-6
1567490
Electromyogr Clin Neurophysiol. 2005 Apr-May;45(3):145-8
15981685
Neurology. 2001 Aug 14;57(3):496-500
11502919
Lupus. 1995 Feb;4(1):67-9
7767342
Mov Disord. 2002 Nov;17(6):1329-35
12465077
Med Klin (Munich). 2002 Dec 15;97(12):730-7
12491066
Stroke. 1989 May;20(5):583-91
2718197
Br J Rheumatol. 1997 Oct;36(10):1067-74
9374923
Pediatr Neurol. 1995 Oct;13(3):191-7
8554655
Neurology. 2003 Jul 8;61(1):108-10
12847168
Curr Opin Rheumatol. 1993 Sep;5(5):575-86
8398608
Arthritis Rheum. 1999 Apr;42(4):599-608
10211873
Neurology. 2002 Apr 23;58(8):1214-20
11971089
Headache. 1990 Mar;30(4):232-5
2335479
Clin Exp Rheumatol. 1999 Jul-Aug;17(4):395-8
10464546
Lupus. 2003;12(12):919-28
14714912
Arthritis Rheum. 1999 Feb;42(2):338-46
10025929
Rheumatology (Oxford). 2002 Jun;41(6):605-18
12048286
Stroke. 1990 Aug;21(8):1226-31
2389304
Neurology. 1992 Sep;42(9):1649-57
1513450
Lupus. 2006;15(4):191-7
16686257
Eur Neurol. 1984;23(4):278-90
6489390
J Rheumatol. 1992 Jan;19(1):47-52
1556699
Am J Med Sci. 2006 Jan;331(1):4-9
16415656
Lupus. 2004;13(3):149-58
15119542
Clin Rheumatol. 2006 Nov;25(6):850-3
16437362
Am J Med. 2005 Dec;118(12):1415
16378793
Psychiatry Clin Neurosci. 2005 Oct;59(5):584-9
16194262
Asian Pac J Allergy Immunol. 2002 Sep;20(3):179-85
12587842